Skip to content
OpenCapital
Get started

OrthoPediatrics KIDS Cash & Equivalents

Cash & Equivalents at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
$21.69B-43.6%
Stryker logo
StrykerSYK
$2.88B+24.1%
Orthofix Medical Inc. logo
Orthofix Medical Inc.OFIX
$120.28M+108%
Zimmer Biomet Holdings logo
Zimmer Biomet HoldingsZBH
$424.2M-69.4%
Medtronic logo
MedtronicMDT
$1.95B-12.1%
Alphatec Holdings logo
Alphatec HoldingsATEC
$139.91M-8.7%

Other financials

Income statement

See full
Revenue$59.4M+13.3%
Gross profit$43.4M+13.4%
Operating income-$8.3M+24.1%
Net income-$10.7M-0.3%
EPS (diluted)-$0.45+2.2%

Balance sheet

See full
Total debt$5.4M+271%
Total equity$338.7M-2.4%
Total assets$502.2M+6.8%

Cash flow

See full
Operating cash flow-$3.3M+20.9%
CapEx$1.8M-58.4%
Free cash flow-$5.0M+39.8%

Valuation

See full
Market cap$503.94M+0.3%
Enterprise value$495.11M+5.7%
P/S2.1×-0.3×

Profitability

See full
Gross margin73.1%+0.3pp
Operating margin-15%-1.6pp
Net margin-16.3%-2.1pp
FCF margin-12.9%-4.3pp

Returns & leverage

See full
Return on equity-11.6%+0.2pp
Debt / equity0×0.0×
Current ratio5.2×-1.0×

Where this comes from

Reported directly by OrthoPediatrics in its filing.

Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents.

The official record: OrthoPediatrics’s 10-Q, filed May 1, 2026, on SEC EDGAR. View the filing →

Ask your AI about OrthoPediatrics's cash & equivalents.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is OrthoPediatrics's cash & equivalents?
OrthoPediatrics (KIDS) reported cash & equivalents of $14.25M in Q1 2026.
How has OrthoPediatrics's cash & equivalents changed year-over-year?
OrthoPediatrics's cash & equivalents decreased by 59.8% year-over-year, from $35.43M to $14.25M.
What is the long-term trend for OrthoPediatrics's cash & equivalents?
Over 5 years (2020 to 2025), OrthoPediatrics's cash & equivalents has grown at a -6.4% compound annual growth rate (CAGR), from $30.13M to $21.62M.
What does cash & equivalents mean?
Cash on hand plus highly liquid investments with maturities of three months or less at purchase — treasury bills, money market funds, and commercial paper.